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Childhood undernutrition remains a major public health concern in 
developing countries, and has in the past been shown to contribute 
to ~50% of the nearly 10 million under-5 children years who die each 
year of preventable causes.[1] Although severe acute malnutrition 
(SAM) is seldom recognised, this condition remains an extremely 
widespread disorder associated with high rates of mortality and 
morbidity, and requires specialised treatment and interventions.[1] 
In an effort to reduce deaths from SAM and improve recovery, 
the World Health Organization (WHO) has developed a ‘10-step’ 
guideline for managing SAM.[2] These guidelines have since been 
promoted as the standard treatment modality for clinical care of 
severely malnourished children.[3] There is evidence to show that if 
implemented correctly, the protocol can improve case fatality rates 
(CFRs) from ~40% to <10%,[4] even when applied in emergency 
humanitarian situations.[5] These guidelines have gained recognition 
worldwide and are now being used in most healthcare units, including 
some hospitals in South Africa (SA).[6]
While numerous studies have established the adverse effects of HIV 
infection on the survival of children treated for SAM,[7-9] few have 
studied the independent effects of HIV clinical stage in particular, 
as well as disease severity at baseline and other critical comorbidities 
on admission. There is also limited or no evidence on the interactive 
effects of these clinical characteristics on increased mortality risk. 
This study was, in part, prompted by the lack of such evidence and 
the fact that in the study setting, the high CFRs for SAM were being 
attributed to HIV infection rather than to mismanagement of SAM 
children by healthcare workers. There was also some anecdotal 
evidence from clinicians in the same hospitals that, depending on 
the clinical stage of HIV infection, the WHO 10-step protocol may 
show no effect. This study therefore sought to establish whether 
there was (i) an independent effect of HIV infection, HIV clinical 
stage, baseline disease severity and other clinical factors on survival 
prospects of children admitted and treated for SAM using the WHO 
10-step guidelines; and (ii) an added risk of death depending on the 
interaction of two or more of these baseline clinical characteristics. 
Methods 
Study setting
This study was conducted in two rural district hospitals located in the 
Eastern Cape Province of SA. The two hospitals were purposefully 
selected on the basis of being the only hospitals in the region that 
had shown optimal implementation of the WHO 10-step guidelines 
and had the basic resources to do so at the time.[10] Furthermore, 
the hospitals serve catchment areas where there is a high HIV 
prevalence. This increased the likelihood of enrolling enough HIV-
positive children with SAM for the purposes of the study.
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Study design
This study consisted of an observational study design with a 
prospective and retrospective component. The prospective aspect 
involved: (i) identifying and classifying multiple cohorts of SAM 
cases admitted to two different hospitals, at different study intervals, 
according to their nutritional and HIV status; (ii) identifying their 
clinical profile on admission; and (iii) initiating them on treatment 
and following them up to assess specific treatment outcomes. The 
retrospective component involved reviewing treatment records, 
which were compiled prospectively to document outcomes of 
interest, and linking this information with baseline characteristics. 
Study sample 
Patient treatment records were only considered for the study if they 
belonged to SAM patients admitted to either of the hospitals between 
January 2009 and May 2013 (the period during which treatment 
of SAM cases was enforced and monitored) and if patients were 
between the ages of 6 months and 5 years. The patient treatment 
records considered also contained clearly defined malnutrition status 
as per the Wellcome classification,[11] had records showing HIV test 
results and HIV clinical stage, and included a complete treatment 
record of the child while in the hospital. The Wellcome system was 
more practical than other classification methods, as there were some 
inconsistencies in the measurement of height/length. A comprehensive 
written medical examination by a doctor and the discharge criteria 
followed for patients who did not die while being treated were also 
used as eligibility criteria. In total, 466 treatment records meeting the 
inclusion criteria were identified from both hospitals during the study 
period. This was ~85% of the total number of treatment records that 
were available during the same period. The records that were selected 
constituted the unit of data abstraction and analysis. 
Patient recruitment 
This study was approved by the University of the Western Cape 
Research Ethics Committee (reg. no. 12/10/37). During the study 
period, the parents or guardians who brought their children with 
SAM to the hospital for treatment were approached in the ward after 
admission and informed about the study. They were then asked to 
provide informed consent for their children to be enrolled in the 
study. For the children whose parents provided consent, the inpatient 
numbers recorded on the treatment charts were noted by a research 
nurse for later reference during retrospective record review. 
Data generation and collection 
Data were extracted from patient treatment records. A structured and 
validated questionnaire developed by the International Malnutrition 
Taskforce and Muhimbili National Hospital, Dar es Salaam, Tanzania[12] 
was used for extraction and collection of all the data. 
SAM classification was done on admission by the admitting 
doctor, based on the Wellcome criteria.[11] Confidential and private 
counselling for HIV testing was conducted by professionally trained 
nurses for all parents and guardians of children with SAM. Parents 
and guardians were also requested to give permission for an HIV 
polymerase chain reaction test to be done for their children. Parents/
guardians provided their own consent and were tested for HIV using 
an enzyme-linked immunosorbent assay test. HIV clinical staging 
was done by the admitting doctor as per the WHO guidelines.[13] 
The admitting doctor also graded oedema and dermatosis on 
admission if they were present, and confirmed the presence of lower 
respiratory tract infections (LRTIs). LRTI was an umbrella term 
used for cases with comorbidities such as pneumonia, bronchitis 
and other infections below the larynx. Tuberculosis (TB) was not 
considered as a comorbidity in this study as the condition was mostly 
underdiagnosed, which resulted in too few cases being included in 
the study to be studied separately. 
Based on diagnostic information, SAM cases were also classified as 
critically ill or not. Definition of a case as critically ill was based on 
whether or not they were admitted with one or a combination of 
five clinical features, i.e.: (i) depressed conscious state (prostration 
or coma); (ii) bradycardia; (iii) evidence of shock with or without 
dehydration; (iv) hypoglycaemia; and (v) hypothermia. These 
clinical manifestations have been documented as the strongest 
predictors of early death (within 24 hours of admission).[14] Other 
comorbidities (excluding LRTIs, TB and HIV/AIDS described above) 
directly or indirectly related to SAM were also noted, e.g. lethargy, 
hyponatraemia and hypokalaemia, dehydration, deep acidotic 
breathing, anaemia and pyrexia, herbal intoxication, diarrhoea, 
burns and other hereditary dysfunctions commonly reported by the 
doctors in each hospital.[14] The outcomes in this study were death 
while under treatment or discharge following treatment completion, 
i.e. survival. 
Data analysis 
All the data were processed and analysed using Stata/IC 13.0 
(StataCorp. LP, USA). Survival analysis was used to assess time to 
death for SAM cases based on baseline clinical characteristics. Firstly, 
Kaplan-Meier failure curves for key characteristics were created and 
compared statistically using log-rank tests. The log-rank test was 
performed among groups for each predictor variable to determine 
whether certain predictors needed to be in the final model. A 
predictor was included in the model if p<0.20. This elimination 
scheme, though arbitrary, allowed for the exclusion of variables that 
were less likely to contribute anything to the model, which included 
other predictors. Therefore, the unadjusted Cox proportional hazard 
model consisted of predictors where p<0.20. The predictors that were 
not statistically significant at univariate level were dropped from 
the final multivariate (adjusted) model. The Cox formulation was 
also used to quantify the impact of the interaction of factors on the 
survival prospects of study subjects, and to identify potential effect 
modifiers. Both the unadjusted, adjusted and interaction models 
were tabulated with hazard ratios (HRs), 95% confidence intervals 
(CIs) and the corresponding p-values. Throughout the analysis, 
p<0.05 was considered statistically significant. The final model 




Over the study period 466 subjects met the study inclusion criteria 
and were considered for the study. However, 12 SAM cases defaulted 
or absconded treatment and were censored during data analysis, 
resulting in 454 cases being analysed. The majority of subjects (50%, 
n=225) were aged between 13 and 24 months, followed by cases aged 
6 - 12 months (36%, n=165). Cases aged 3 - 5 years constituted only 
14% of the study sample. 
Pooled data revealed that the proportion with marasmus and 
kwashiorkor was similar (38% and 40%, respectively), whereas only 
22% were classified as marasmus-kwashiorkor (Table 1). About a 
quarter (28%) of SAM cases had LRTIs on admission, and a third had 
other comorbidities, the most common being gastroenteritis (11%). In 
both hospitals, the most commonly diagnosed LRTI was pneumonia. 
Pooled data also showed that 196 (43%) were HIV-positive. In total, 
the majority who tested positive for HIV were classified as disease 
stage III (37%), followed by those who were at stage II (26.5%), 
then 19% and 17% for stages I and IV, respectively. Approximately 
26% of SAM cases were admitted in a critical condition as per study 
definition. The combined CFR was 24.4%. 
Pooled analysis revealed that more HIV-positive SAM patients 
were marasmic compared with their HIV-negative counterparts 
(56% and 24%, respectively, p<0.001) (Table 2). The reverse was 
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Table 1. Comparison of clinical characteristics of SAM cases by hospital on admission (N=454)
Variable Hospital A Hospital B
Both hospitals 
combined p-value*
Severe malnutrition classification 0.171
Marasmus 59 (40.9)   114 (36.8) 173 (38.1)
Kwashiorkor 61 (42.4)   120 (38.7) 181 (39.9)
Marasmus-kwashiorkor 24 (16.7)   76 (24.5) 100 (22.0)
Oedema grade 0.851
None 52 (36.1) 101 (32.6) 153 (33.7)
Mild 9 (6.2) 20 (6.4) 29 (6.4)
Moderate 39 (27.0) 83 (26.7) 122 (26.9)
Severe 44 (30.6) 106 (34.2) 150 (33.1)
Dermatosis grade 0.122
None 36 (25.0) 100 (32.6) 136 (29.9)
Mild 43 (29.8) 63 (20.3) 106 (23.4)
Moderate 47 (32.6) 110 (35.5) 157 (34.6)
Severe 18 (12.5) 37 (11.9) 55 (12.1)
LRTIs 0.156
Yes 48 (33.3) 83 (26.7) 131 (28.9)
No 96 (66.7) 227 (73.3) 323 (71.2)
Other comorbidities 0.140
Yes 55 (38.2) 97 (31.3) 152 (33.4)
No 89 (61.8) 213 (68.7) 302 (66.5)
Critically ill on admission 0.344
Yes 33 (22.9) 84 (27.1) 117 (25.7)
No 111 (77.1) 226 (72.9) 337 (74.2)
HIV status 0.001
Positive 78 (54.1) 118 (38.0) 196 (43.2)
Negative 66 (45.8) 192 (61.9) 258 (56.8)
HIV/AIDS disease stage 0.191
1 18 (23.0) 16 (13.6) 34 (17.4)
2 22 (28.2) 30 (25.4) 52 (26.5)
3 23 (29.4) 50 (42.7) 73 (37.2)
4 15 (19.2) 22 (18.6) 37 (18.8)
Outcome 0.960
Died 34 (24.3) 74 (24.5) 108 (24.4)
Discharged 106 (75.7) 228 (75.7) 334 (75.6)
*p-values are for differences in variable categories based on pooled data (data for both hospitals combined).
Table 2. Cross-tabulation of cases by SAM syndromic classification and HIV status: Hospital-level and pooled analyses  
(2009 - 2013)
Clinical classification of severe malnutrition, n (%)
Marasmus Kwashiorkor Marasmus-kwashiorkor Total, n 
Hospital A
HIV-negative 15 (22.7) 41 (62.1) 10 (15.2) 66                    
HIV-positive 44 (56.4) 20 (25.6) 14 (17.9) 78                    
Total 59 (40.9) 61 (42.3) 24 (16.7) 144                  
Hospital B 
HIV-negative 48 (25.0) 98 (51.0) 46 (23.9) 192                  
HIV-positive 66 (55.9) 22 (18.6) 30 (25.4) 118                  
Total 114 (36.8) 120 (38.7) 76 (25.5) 310                  
Both hospitals combined
HIV-negative 63 (24.4) 139 (53.8) 56 (21.7) 258                  
HIV-positive 110 (56.1) 42 (21.4) 44 (22.5) 196                  
Total 173 (38.1) 181 (39.9) 100 (22.3) 454                  
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true for cases who had kwashiorkor, where 
53% were HIV-negative and 21% HIV-
positive (p<0.001). The same direction of 
differences was also observed at the level 
of individual hospitals, with a similar 
statistical significance (p<0.001). For cases 
with marasmus-kwashiorkor, there were 
no statistically significant differences across 
HIV status (p>0.05).
Survival analysis 
Univariate survival analysis 
Based on the log-rank test for equality of 
failure functions, mortality hazard did not 
differ significantly by hospital (p=0.341). 
Hence, for subsequent analysis the hospitals 
were combined.
In this study, 41.15% of HIV-positive and 
11.6% of HIV-negative SAM cases died while 
under treatment (p<0.001)(Fig. 1). HIV-
positive cases had worse survival prospects 
than their HIV-negative counterparts in 
both hospitals (p<0.001). As shown in the 
graph, the cumulative fraction of HIV-
positive SAM cases who had died by day 6 
post admission was 25% compared with 
HIV-negative cases, which was about 5% at 
the same time point. These results imply that 
HIV-positive cases generally died sooner 
and in greater numbers following admission, 
than their HIV-negative counterparts. Stage 
IV cases had the worst survival prospects 
followed by their stage III counterparts. 
The difference between these two groups 
was statistically significant (p<0.01) as was 
the difference between stage I and stage II 
SAM cases (p=0.043) and stage II and stage 
III cases (p<0.001). These results may imply 
that the critical stage for higher risk of death 
was when cases were admitted at stage III.
Approximately 25% of children admitted 
in a critical condition had died by the 
second day, compared with only 1% of the 
non-critically ill group (p<0.001) (Fig. 2). 
Mortality patterns beyond the second day 
showed that ~75% of critically ill children 
with SAM had died by the 28th day after 
hospitalisation, compared with about 
17% who were not critically ill. Survival 
prospects for SAM cases who were admitted 
with marasmus were significantly poorer 
compared with cases who had either 
kwashiorkor or marasmic-kwashiorkor 
(p=0.001). No differences were found between 
cases that had kwashiorkor and marasmus-
kwashiorkor (p=0.052). Furthermore, the 
presence of other comorbidities and co-
infection with LTRIs/TB was associated with 
excess mortality.
Cox proportional hazard model
Univariate results 
The univariate results shown in Table 3 
indicate that only HIV status and stage, 
critical illness on admission, other baseline 
comorbidities, LRTIs and the three SAM 
syndromic classifications were significantly 
associated with increased hazard of death. For 
patients with severe oedema, the hazard of 
death was 46% less than the hazard of dying 
among those who had no oedema (p=0.001). 
Before risk factor adjustment, cases who had 
LRTIs had about a four times higher hazard 
of death compared with those who did not 
(HR 3.66, p<0.001). Patients admitted with 
other comorbidities at baseline had almost a 














































Fig. 2. Kaplan-Meier failure curves for SAM cases stratified by SAM class, presence of LRTI(s), presence of 
other comorbidities and critical illness.
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two-fold higher hazard of death than those admitted without (HR 1.94, 
p=0.001). 
HIV status and case severity were the strongest predictors of death 
in the unadjusted model. Children who were critically ill on admission 
had a five times higher hazard of death than those who were not (HR 
5.70, p<0.001). Children who were HIV-positive and at stage IV or III 
of infection had, respectively, eight times higher (HR 8.12, p<0.001) 
and five times higher (HR 5.73, p<0.001) hazard of death than their 
HIV-negative counterparts. Stages II and I of HIV infection were not 
statistically significant predictors of mortality (p>0.05). 
Multivariate results 
After multivariate adjustments, hospital, age, SAM syndromic classifi- 
cations, dermatosis grade, other baseline comorbidities and oedema 
grade were not significantly associated with increased risk of death. 
After multivariate adjustment, the hazard rate was reduced to 1.75 
for children who had LRTIs at baseline, but remained statistically 
significant (p=0.001). HIV status and case severity were again the 
strongest predictors of death in adjusted models. Children who were 
critically ill on admission had a three-and-a-half times higher hazard 
of death than those who were not (HR 3.64), a result which was 
Table 3. Univariate (unadjusted) and multivariate (adjusted) Cox proportional hazard models for factors associated with 
mortality among children with SAM during the intervention period
Unadjusted model Adjusted model *
Factors n/N UHR 95% CI p-value AHR 95% CI †p-value
Hospital  
Hospital A 34/140 Ref Ref
Hospital B 74/302 1.22 0.81 - 1.84 0.346 1.55 0.91 - 1.92 0.401
Age (months)
6 - 12 46/164 Ref
13 - 24 47/225 0.73 0.49 - 1.11 0.147 0.93 0.61 - 1.43 0.771
25 - 61 14/64 0.74 0.41 - 1.36 0.345 0.61 0.32 - 1.15 0.129
SAM classification
Marasmus 63/173 Ref Ref
Kwashiorkor 30/171 0.44 0.29 - 0.69 <0.001 1.21 0.42 - 3.45 0.806
M-kwashiorkor 16/98 0.44 0.25 - 0.77 0.004 0.53 0.20 - 1.43 0.080
Oedema grade
None 54/153 Ref Ref
Mild 6/29 0.55 0.24 - 1.29 0.171 0.58 0.22 - 1.53 0.109
Moderate 23/119 0.52 0.31 - 0.84 0.009 1.16 0.43 -  3.07 0.675
Severe 29/141 0.46 0.29 - 0.74 0.001 0.61 0.20 - 1.83 0.682
Dermatosis grade
None 32/134 Ref Ref
Mild 23/102 0.88 0.52 - 1.51 0.652 0.69 0.37 - 1.26 0.851
Moderate 33/153 0.90 0.56 - 1.47 0.686 1.03 0.59 - 1.80 0.439
Severe 20/53 1.73 0.10 - 1.04 0.052 1.43 0.76 - 2.66 0.088
LRTIs 
No 47/314 Ref Ref
Yes 61/128 3.66 2.50 - 5.36 <0.001 1.74 1.12 - 2.70 0.001
Other baseline 
comorbidities
No 56/294 Ref Ref
Yes 52/148 1.94 1.33 - 2.84 0.001 1.14 0.74 - 1.76 0.880
Critically ill at baseline 
No 44/328 Ref                              Ref
Yes 64/114 5.70 3.87 - 8.39 <0.001 3.64 2.35 - 5.64 <0.001
HIV status and stage
Negative 29/250 Ref  Ref
Positive/stage I 2/33 0.46 0.11 - 1.94  0.231 0.20  0.03 - 1.53 0.312
Positive/stage II 9/50 1.44 0.68 - 3.05  0.189 1.12  0.51 - 2.49 0.223
Positive/stage III 40/72 5.73 3.54 - 9.25  <0.001 3.18  1.85 - 5.47 <0.001
Positive/stage IV 28/37 8.12 4.82 - 13.66  <0.001 3.74  2.05 - 6.84 <0.001
n/N = number of failure cases over total number of cases; UHR = unadjusted hazard ratio; AHR = adjusted hazard ratio; Ref = reference group;  
M-kwashiorkor = marasmus-kwashiorkor. 
*The global test for hazard proportionality revealed that the overall multivariate model did not significantly violate the proportional hazards assumption (p-value=0.184). 
Overall, the variance inflation factor (VIF) for the model was 2.87 which was less than the cut-off point of VIF=10. 
†p=95% level of significance.
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statistically significant (p<0.001). Severely malnourished children 
who were HIV-positive and at stage III or IV had, respectively, a five 
times higher (HR 8.12, p<0.001) and eight times higher (HR 5.73, 
p<0.001) hazard of death than their HIV-negative counterparts. The 
HRs dropped by about three units for stages III and IV, but remained 
statistically significant (p<0.001). At multivariate level, stages I and 
II of HIV infection remained not statistically significant predictors 
of mortality (p>0.05). 
Interaction survival modelling 
Children who had LRTIs at baseline and were critically ill at the 
same time had a 14 times higher hazard of death compared with 
those who had none (p<0.001) (Table 4). Furthermore, children who 
were HIV-positive and critically ill on admission had the highest 
hazard of death (HR 22, p<0.001) compared with those who were 
not exposed to any of the three risk factors. SAM cases who were 
HIV-positive and had LRTIs had only a nine times higher hazard of 
death (p<0.001). A striking result was that the hazard of death was 
slightly lower (HR 19, p<0.001) for cases who were HIV-positive, had 
LRTIs and were critically ill on admission compared with those who 
only had HIV infection and were critically ill on admission (HR 22, 
p<0.001). In comparison with cases that had none of the risk factors, 
those who were exposed to only one of the three risk factors had lower 
hazards of death than those who were exposed to more than one. The 
predictive power of one risk factor during interaction analysis was not 
statistically significant (p>0.05), except for critical illness (p=0.001).
Discussion 
This study adds an arguably new and important dimension to what 
already exists in the literature around the management of SAM in the 
context of HIV infection. In addition to HIV status itself, the study 
revealed independent and interactive effects of HIV disease stage, 
baseline disease severity and other baseline comorbidities on mortality 
within the context of the WHO 10-step treatment modality in two 
resource-limited healthcare facilities in SA. 
With regard to the burden of HIV infection, the combined prevalence 
in both hospitals was slightly lower (43%) than that reported in a 
similar and recent study conducted in SA (51%),[9] but higher than that 
reported in a study conducted in Malawi (14%).[7] The current study 
also confirmed findings from other studies that HIV-infected SAM 
cases were more likely to present with marasmus than kwashiorkor 
on admission.[8,15] While it is usual to present with kwashiorkor in the 
southern African region, with the high prevalence of HIV infection, 
SAM patients become wasted owing to changes in physiological and 
metabolic functions associated with HIV infection.[16] 
This study also examined the independent effect of HIV infection on 
survival. The CFRs in this study were higher in the HIV-infected group 
(41%) compared with their HIV-uninfected counterparts (11%). These 
estimates were slightly higher than those recently reported in Burkina 
Faso (39.7% v. 10.9% for HIV-infected and HIV-uninfected cases, 
respectively).[17] A study in Niger also reported the same direction of 
relationship but with much lower CFRs for HIV-infected and HIV-
uninfected SAM cases (20% and 14%, respectively).[18]
In this study we have shown that disease severity at baseline was 
independently associated with excess mortality, a finding that is 
consistent with past evidence by Maitland et al.[14] Children with SAM 
who were admitted with one or a combination of clinical features 
such as coma, hypoglycaemia, hypothermia and bradycardia, had the 
worst survival probability compared with those who had other less 
SAM-related manifestations, such as herbal intoxication, Cushingoid 
facies, etc. These findings may have important practical implications. 
As Maitland et al.[14] have argued, the clinical features associated with 
higher risk of death can be used by frontline healthcare givers to target 
emergency treatment and allocate resources more appropriately. This 
is particularly important in the context of poor human and material 
resources in most rural hospitals in sub-Saharan Africa, such as 
those in which the current study was conducted. With mortality 
being highest in the first 5 days of admission, there is a need to 
institute proper, well-supported and sustained triage and emergency 
management mechanisms so that the ‘at higher risk of death’ cases 
are identified and treated according to the available guidelines. 
Continued attention to appropriate diagnosis and treatment of 
common complications such as LRTIs also needs to be prioritised, 
as they were shown to be strongly associated with excess mortality 
in this study. Such complications do not always require a specialist 
physician and can be managed by most professional nurses in SA, 
with minimal supervision from a physician. It is worth noting 
that TB was found to be less common in the study sample than 
other LRTIs. This is probably because TB was difficult to diagnose 
microbiologically in the study setting, despite it being an important 
comorbidity in the management of SAM in the context of HIV 
infection. The challenge of TB diagnosis has been documented 
before among HIV-infected children with SAM in whom the 
tuberculin skin test is often falsely negative.[9]
Perhaps what the current study adds to the body of knowledge is 
the pattern of survival among HIV-infected SAM cases that were at 
different stages of HIV infection. Cox regression analyses revealed 
that the threshold for higher risk of death was when children with 
SAM were admitted at stage III. The reasons for excess mortality 
risk associated with advanced stages of HIV infections in SAM are 
Table 4. Cox proportional hazard model for interaction of factors associated with mortality among children with SAM admitted to 





Critically ill at 
baseline n/N HR 95% CI p-value
9/165 Ref
0 0 1 9/35 4.83 1.92 - 12.18 <0.001
0 1 0 3/35 1.55 0.42 - 5.71 0.532
0 1 1 8/15 14.64 5.64 - 38.01 <0.001
1 0 0 12/89 2.18 0.92 - 5.19 0.411
1 0 1 17/25 22.00 9.78 - 49.49 <0.001
1 1 0 20/39 9.86 4.49 - 21.68 <0.001
1 1 1 30/39 19.79 9.39 - 41.73 <0.001
*0 = no; 1 = yes.
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not yet well understood, particularly in the context of antiretroviral 
therapy (ART).[19] However, some authors continue to attribute 
excess mortality to complex pathophysiological, metabolic and 
pharmacological changes that occur as HIV infection progresses.[17] 
HIV-infected SAM patients in the current study were initiated on 
ART using the standard guidelines. However, the timing of ART in 
preventing premature mortality among HIV-infected SAM cases at 
different disease stages remains a challenge. A randomised controlled 
trial has shown that half the children hospitalised for SAM developed 
oedema after starting ART.[20] In the same study, one in 14 children 
who were at an advanced stage of HIV infection became oedematous 
12 weeks after ART initiation. 
Another contribution of this study is the demonstration of the 
interactive effects of multiple clinical risk factors on mortality in the 
study sample. A study by Koethe and Heimburger[21] has shown that 
SAM, immune function and infection burden interact in children, 
particularly in the context of HIV infection. In this study, being 
critically ill and having LRTIs were, both independently and as a 
combination, potential effect modifiers of the higher risk of death, 
as they increased the hazard of death quite substantially when they 
were combined with HIV infection in the interaction model. The 
interaction model of HIV infection, LRTIs and baseline disease 
severity also revealed that in comparison with patients who had none 
of these risk factors, those who were exposed to only one of the three 
risk factors had lower hazards of death than those who were exposed 
to more than one. These findings also speak to a need to develop a 
triage system that helps healthcare workers to prioritise cases that are 
at higher risk of death. 
Finally, it is also worthy to note that the combined CFR of 24.4% 
shown in this study is much higher than the WHO target of <5% in 
the context of the WHO 10-step treatment modality, implying that 
achieving this target may be unrealistic, particularly among HIV-
infected cases in resource-limited settings. De Maayer and Saloojee[9] 
have also shown that, even in resource-privileged SA settings, the 
WHO target of <5% may be impractical. 
Study limitations 
This study was conducted in two rural facilities to determine 
whether the findings would be similar. However, although we found 
similarities in results, these may not be generalisable beyond the 
study setting. There may be a layer of both internal and external 
facility-specific factors that determined treatment outcomes for 
SAM. Furthermore, the current study did not investigate how such 
factors may have influenced the process of care and the treatment 
outcomes thereof. 
Study recommendations
We recommend that a carefully controlled study, such as a randomised 
controlled trial, be conducted to make a better judgement about the 
effects of the risk factors reported here on mortality in the context of 
the WHO treatment guidelines. 
Conclusion 
Within the context of increased ART and prevention of mother-to-
child transmission (PMTCT) coverage in SA, there seems to be hope 
that the impact of HIV infection on SAM-CFRs among children may 
be reduced. However, given the limited evidence on the most effective 
ways of managing SAM patients who are HIV infected, this group of 
patients will continue to pose some challenges to the healthcare 
workforce. The high HIV prevalence rate in the study population 
and the resultant treatment outcomes lend support to the notion 
that the WHO treatment guidelines should be revised to ensure that 
mechanisms for effective treatment of HIV comorbidity in SAM 
are in place. The revisions ought to tap into the differential energy 
requirements by HIV status, timing of ART initiation among HIV-
infected SAM cases as well as developing a broad-based triage system 
to more effectively identify and treat SAM cases that are at higher 
risk of early death. However, the target of <5% CFR may be difficult 
to achieve, particularly for HIV-positive SAM cases, as has been 
suggested in our study findings. The role of the broader healthcare 
system in SA in preventing incidences of SAM at community level 
in the study setting is discernible. The current study has shown 
that the admission rates attributable to SAM at both hospitals 
remain high, and as such require mitigation. Community-based 
prevention strategies developed through multisectoral engagements 
have a huge role to play in achieving this goal. It goes without saying 
that early detection of SAM would be a crucial part of preventing 
disease severity and the development of multiple infections, thereby 
reducing the likelihood of subsequent preventable death associated 
with SAM in the study setting. The close linkage between SAM and 
HIV/AIDS begs an integrated healthcare approach to ensure that 
hospitals and HIV clinics work in harmony to optimise outcomes 
for both the child and the mother. Strengthening PMTCT services 
in resource-limited settings would also likely reduce the burden of 
HIV infection among children, and mitigate the risk of developing 
severe malnutrition. 
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